Read More Pharma Industry News Novo Nordisk gets UK nod for single-dose Wegovy 7.2mg pen in obesity care MHRA has approved the single-dose Wegovy 7.2mg pen for adults with obesity in the United Kingdom. Read what it means for patients and Novo Nordisk. byVenkateshApril 14, 2026